ArticleViruses2024

Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses.

Harry Ridgway et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.